Armata Pharmaceuticals, Inc.
ARMP$431M
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaLOS ANGELES60 employees
Drugs in Pipeline
7
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ARMP News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
C16G2 Gel
Dental Caries
C16G2
Dental Caries
AP-PA02
Non-cystic Fibrosis Bronchiectasis
C16G2 Varnish
Dental Caries
C16G2 Rinse
Dental Caries
C16G2 Strip
Dental Caries
AP-SA02
Bacteremia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
C16G2 Gel | Phase 2 | Dental Caries | - | - |
C16G2 | Phase 2 | Dental Caries | - | - |
AP-PA02 | Phase 2 | Non-cystic Fibrosis Bronchiectasis | - | - |
C16G2 Varnish | Phase 2 | Dental Caries | - | - |
C16G2 Rinse | Phase 2 | Dental Caries | - | - |
C16G2 Strip | Phase 2 | Dental Caries | - | - |
AP-SA02 | Phase 2 | Bacteremia | - | - |
Dental Caries
5 drugs in this indication
Non-cystic Fibrosis Bronchiectasis
1 drug in this indication
Bacteremia
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply